Rothschild & Co Asset Management US’s AngioDynamics ANGO Stock Holding History

Rothschild & Co Asset Management US’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-97,472	Closed	-$1.79M	–	351
2019 Q3	$1.79M	Buy	97,472 +4,570	+5%	+$89.4K	0.02%	310
2019 Q2	$1.83M	Hold	92,902	–	–	0.02%	308
2019 Q1	$2.12M	Sell	92,902 -328	-0.4%	-$7.12K	0.02%	309
2018 Q4	$1.88M	Sell	93,230 -517	-0.6%	-$10.7K	0.02%	327
2018 Q3	$2.04M	Sell	93,747 -3,982	-4%	-$88.4K	0.02%	337
2018 Q2	$2.17M	Sell	97,729 -3,610	-4%	-$73.8K	0.02%	335
2018 Q1	$1.75M	Sell	101,339 -10,601	-9%	-$177K	0.02%	320
2017 Q4	$1.86M	Sell	111,940 -6,372	-5%	-$109K	0.02%	321
2017 Q3	$2.02M	Buy	118,312 +1,400	+1%	+$23.5K	0.02%	306
2017 Q2	$1.9M	Buy	116,912 +357	+0.3%	+$5.64K	0.02%	324
2017 Q1	$2.02M	Sell	116,555 -5,057	-4%	-$84.6K	0.02%	321
2016 Q4	$2.05M	Buy	121,612 +7,196	+6%	+$120K	0.03%	335
2016 Q3	$2.01M	Buy	+114,416	New	+$1.86M	0.03%	315

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rothschild & Co Asset Management US's ANGO Position: Q4 2019 in Review

Rothschild & Co Asset Management US sold out of AngioDynamics (ANGO) in Q4 2019, closing a stake of 97,472 shares — an estimated $1.79M sold.

Rothschild & Co Asset Management US first reported a position in ANGO in Q3 2016 and held it in 13 quarters. The position peaked at $2.17M in Q2 2018. 157 funds tracked by Wall St. Rank hold ANGO as of Q4 2019.

Rothschild & Co Asset Management US reported no remaining AngioDynamics position as of Q4 2019 after selling out during the quarter.
Rothschild & Co Asset Management US sold 97,472 AngioDynamics shares in Q4 2019, an estimated $1.79M.
Rothschild & Co Asset Management US first reported a position in AngioDynamics in Q3 2016 and held it in 13 quarters.
Rothschild & Co Asset Management US's AngioDynamics position peaked at $2.17M in Q2 2018.
157 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2019.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2019, filed 12 Feb 2020.